Work

Interleukin-23 (IL-23) inhibitor, mirikizumab in the treatment of ulcerative colitis (UC): a promising therapy?

Year: 2025

Type: article

Source: Journal of Basic and Clinical Physiology and Pharmacology

DOI: 10.1515/jbcpp-2024-0102

Authors: Saurav Misra, Manmeet Kaur, Ashish Kumar Saranjhna

Institution: Kalpana Chawla Government Medical College and Hospital

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416738734

FWCI:

Cites: 24

Cited by:

Related to: